Trademark: 98340127
Word
REGENEX
Status Date
Thursday, August 22, 2024
Filing Date
Wednesday, January 3, 2024
Published for Opposition
Tuesday, July 23, 2024
5 Regenerative injectable fillers containing natural growth factors, namely, injectable fillers in the nature of mesenchymal stem cells and bone marrow concentrate for medical use; Blood-derived pharmaceutical preparations for the treatment of orthopedic injuries; therapeutic and regenerative products, namely, blood components in the nature of stem cells and bone marrow concentrate for medical use; dietary and nutritional supplements
44 Medical clinics; medical consultations; medical services; medical services utilizing stem cell therapy procedures; medical services, namely, tissue regeneration; medical services in the field of diagnostics and interventional orthopedics; medical diagnosis and treatment of orthopedic injuries; medical evaluation of orthopedic injuries; medical procedures, namely, treatments using specially formulated stem cells, bone marrow concentrate, and other blood components; regenerative medicine services, namely, providing regenerative therapies for pain relief
The mark consists of the stylized wording "REGENENEXX" wherein the last stylized letter "X" is in superscript and to the right of the remaining stylized lettering "REGENEX." Both letters "X" are segmented.
REGENEXX
Color is not claimed as a feature of the mark.
Jan 3, 2024
New Application Entered
Apr 25, 2024
New Application Office Supplied Data Entered
Jun 12, 2024
Assigned To Examiner
Jun 20, 2024
Notification Of Examiners Amendment E-Mailed
Jun 20, 2024
Examiners Amendment E-Mailed
Jun 20, 2024
Examiners Amendment -Written
Jun 20, 2024
Examiner's Amendment Entered
Jun 20, 2024
Approved For Pub - Principal Register
Jul 3, 2024
Notification Of Notice Of Publication E-Mailed
Aug 22, 2024
Opposition Papers Received At Ttab
Jul 23, 2024
Published For Opposition
Jul 23, 2024
Official Gazette Publication Confirmation E-Mailed
Aug 22, 2024
Opposition Instituted No. 999999
Trademark Alertz updated from USPTO on 2030-01-24
